These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27044119)

  • 1. Letter From The Editor.
    Rabasseda X
    Drugs Today (Barc); 2016 Jan; 52(1):5. PubMed ID: 27044119
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical advertising in medical journals.
    Lexchin J
    Can Med Assoc J; 1984 Sep; 131(6):544-6. PubMed ID: 6478335
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical advertisements in Australian medical publications--have they improved?
    Carandang ED; Moulds RF
    Med J Aust; 1994 Dec 5-19; 161(11-12):671-2. PubMed ID: 7830633
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial.
    Audus KL
    J Pharm Sci; 2015 Feb; 104(2):288-9. PubMed ID: 25594867
    [No Abstract]   [Full Text] [Related]  

  • 5. How to write a letter to the editor that the editor will want to publish.
    Morgan PP
    Can Med Assoc J; 1985 Jun; 132(12):1344. PubMed ID: 4005719
    [No Abstract]   [Full Text] [Related]  

  • 6. [An analysis of medical advertising].
    Abraham RE
    Ned Tijdschr Geneeskd; 1967 Feb; 111(5):205-10. PubMed ID: 6042283
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceutical advertising. Information or influence?
    Dixon T
    Can Fam Physician; 1993 Jun; 39():1298-300, 1302-4. PubMed ID: 8324397
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drugs and biomedical journals: better information, more precision].
    López Briz E; Chicano Piá P
    Med Clin (Barc); 1997 Jun; 109(3):117. PubMed ID: 9289515
    [No Abstract]   [Full Text] [Related]  

  • 9. Mea maxima culpa!: Letter to the new editor…From your new editor.
    Preffer FI
    Cytometry B Clin Cytom; 2012 Mar; 82(2):. PubMed ID: 22344844
    [No Abstract]   [Full Text] [Related]  

  • 10. A special new year.
    Wiegers W; Wenzel R
    Arzneimittelforschung; 2012 Jan; 62(1):3. PubMed ID: 22331754
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial.
    Wehling M
    Drug Res (Stuttg); 2013 Jan; 63(1):1. PubMed ID: 23447039
    [No Abstract]   [Full Text] [Related]  

  • 12. The extent of advertising of pharmaceutical products.
    Stimson GV
    J R Coll Gen Pract; 1976; 26 Suppl 1(Suppl 1):69-76. PubMed ID: 1011223
    [No Abstract]   [Full Text] [Related]  

  • 13. The journal and drug advertising.
    Jureidini J; Mansfield P
    Aust N Z J Psychiatry; 2003 Aug; 37(4):495; discussion 495. PubMed ID: 12873340
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug advertisements in Indian medical journals.
    Lal A; Sharma ML
    Indian J Physiol Pharmacol; 1992 Apr; 36(2):139-40. PubMed ID: 1506082
    [No Abstract]   [Full Text] [Related]  

  • 15. The wind of change: respecting the past, embracing the future.
    Wehling M
    Arzneimittelforschung; 2012 Jan; 62(1):1-2. PubMed ID: 22331753
    [No Abstract]   [Full Text] [Related]  

  • 16. Who reviews the ads?
    Relman AS
    N Engl J Med; 1979 Nov; 301(18):999. PubMed ID: 492232
    [No Abstract]   [Full Text] [Related]  

  • 17. 'ArzneiForsch/DrugRes'--Active presence in the Internet.
    Arzneimittelforschung; 1999 Jan; 49(1):1-3. PubMed ID: 10028371
    [No Abstract]   [Full Text] [Related]  

  • 18. Scientific paper or political 'white paper'?
    Fisher DW
    Hosp Pract (Off Ed); 1992 Jul; 27(7):13, 16. PubMed ID: 1629259
    [No Abstract]   [Full Text] [Related]  

  • 19. Writing a letter to the Editor.
    Peh WC; Ng KH
    Singapore Med J; 2010 Jul; 51(7):532-5. PubMed ID: 20730391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintain the goals of Drug Metabolism and Drug Interactions.
    Siest G
    Drug Metabol Drug Interact; 2012; 27(4):183-4. PubMed ID: 23183743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.